Thermo Fisher Scientific's Q1 Earnings Preview: Analysts Expect 3.1% EPS Growth

Thermo Fisher Scientific Inc. is expected to report Q1 2026 earnings with analysts predicting a profit of $5.31 per share, up 3.1% from the year-ago quarter. The company's stock has underperformed the S&P 500 Index and State Street Health Care Select Sector SPDR ETF over the past 52 weeks, but analysts have a bullish consensus opinion with a "Strong Buy" rating overall. The average analyst price target is $665.28, indicating a potential upside of 36.1% from current levels.